Market closedNon-fractional

Integra LifeSciences/IART

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About Integra LifeSciences

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

Ticker

IART

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Equipment and Supplies

Headquarters

Princeton, United States

Employees

3,946

IART Metrics

BasicAdvanced
$2.3B
Market cap
57.27
P/E ratio
$0.51
EPS
1.17
Beta
-
Dividend rate
$2.3B
1.17
4.681
3.062
125.679
127.945
4.53%
4.00%
2.46%
57.27
1.51
1.43
-4.93
37.82
-2.07%
-75.31%
3.55%
-36.53%

What the Analysts think about IART

Analyst Ratings

Majority rating from 14 analysts.
Hold

IART Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-0.86% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$369M
-7.10%
Net income
-$3.2M
-116.16%
Profit margin
-0.86%
-117.27%

IART Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 0.30%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.71
$0.76
$0.89
$0.55
-
Expected
$0.57
$0.78
$0.90
$0.55
$0.62
Surprise
24.76%
-2.30%
-1.46%
-0.30%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Integra LifeSciences stock?

Integra LifeSciences (IART) has a market cap of $2.3B as of July 04, 2024.

What is the P/E ratio for Integra LifeSciences stock?

The price to earnings (P/E) ratio for Integra LifeSciences (IART) stock is 57.27 as of July 04, 2024.

Does Integra LifeSciences stock pay dividends?

No, Integra LifeSciences (IART) stock does not pay dividends to its shareholders as of July 04, 2024.

When is the next Integra LifeSciences dividend payment date?

Integra LifeSciences (IART) stock does not pay dividends to its shareholders.

What is the beta indicator for Integra LifeSciences?

Integra LifeSciences (IART) has a beta rating of 1.17. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Integra LifeSciences stock

Buy or sell Integra LifeSciences stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing